Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

Completed

Conditions studied: Renal Cell Carcinoma

In brief

This study aims at estimating the proportion of patients diagnosed with locoregional renal cell carcinoma who are at high risk for recurrence following nephrectomy, describe referral patterns, and characterize treatment in this population. Outcomes including estimation of the incidence of recurrence and disease-free interval following nephrectomy will be reported overall and among the subgroup off patients receiving adjuvant systemic therapy with sunitinib following nephrectomy.

Key facts

Study ID

NCT04309617

Run by

Pfizer

People needed

618

Starts

2019-07-31

Expected to finish

2020-04-28

Last updated by the study team

2021-05-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must meet all of the following inclusion criteria to be eligible for data abstraction:
• Diagnosed with locoregional RCC (no distant metastasis at the time of diagnosis)
• Underwent a nephrectomy at Duke between 01 April 2014, and 31 December 2019 (final dates determined based on results from part 2 data collection)
• Aged 18 years or older at nephrectomy

You may not qualify if…

• none

Where it is running

• Duke University — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.